8-K: Johnson & Johnson to Return to Tort System After Bankruptcy Court Denies Talc Settlement Plan

Johnson & Johnson will reverse approximately $7 billion in reserves after the U.S. Bankruptcy Court denied its subsidiary's request to confirm its proposed prepackaged bankruptcy plan related to talc claims.

Summary

• The U.S. Bankruptcy Court for the Southern District of Texas denied Red River Talc LLC's request to confirm its proposed prepackaged bankruptcy plan.
• Johnson & Johnson will return to the tort system to litigate and defeat talc claims it considers meritless.
• The company will reverse approximately $7 billion from amounts previously reserved for the bankruptcy resolution.
• Johnson & Johnson believes the talc litigation is a plaintiff-lawyer driven fake tort, premised on junk science and fueled by third party litigation financing.
• The company has no intent to settle or pay plaintiff lawyers on such meritless claims.
• Johnson & Johnson prevailed in 16 of 17 ovarian cases tried in the last 11 years.
• The company has settled 95% of filed mesothelioma lawsuits, concluded all State consumer protection claims, as well as all talc-supplier disputes.
• Johnson & Johnson will conduct a conference call with investors on April 1, 2025, to discuss the announcement.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company expresses confidence in its legal position, the denial of the bankruptcy plan introduces uncertainty and potential costs associated with prolonged litigation. The reversal of the reserve is a positive, but the overall situation remains complex.

Positives

• Johnson & Johnson will reverse approximately $7 billion of previous reserve.
• The company prevailed in 16 of 17 ovarian cases tried in the last 11 years.
• Johnson & Johnson has settled 95% of filed mesothelioma lawsuits, concluded all State consumer protection claims, as well as all talc-supplier disputes.

Negatives

• The U.S. Bankruptcy Court denied Red River Talc LLC's request to confirm its proposed prepackaged bankruptcy plan.
• The company will now have to litigate talc claims in the tort system, which could be a lengthy and costly process.

Risks

• The company faces ongoing litigation related to talc claims.
• The company's reputation could be negatively impacted by the talc litigation.
• The company's financial results could be negatively impacted by the talc litigation.

Future Outlook

The Company will return to the tort system to litigate and defeat these meritless talc claims and vigorously present its case in the tort system, starting with the adjudication of the motions pending in the Multi-District Litigation to exclude plaintiffs experts and to disqualify the lead counsel for its unethical breaches.

Management Comments

• Erik Haas, Worldwide Vice President of Litigation, stated that the company is more confident than ever in its position in the tort system.
• Mr. Haas also stated that the company will devote its efforts to defeating these fake claims.
• Mr. Haas reiterated that none of the talc-related claims against it have merit and attempts to resolve this litigation were aimed at moving past this issue.

Industry Context

This announcement highlights the ongoing challenges faced by companies dealing with mass tort litigation, particularly in cases involving alleged links between products and health issues. The decision to return to the tort system reflects a strategic shift after the bankruptcy route was unsuccessful.

Comparison to Industry Standards

• The use of the bankruptcy system to resolve mass tort claims has been employed by other companies facing similar liabilities, such as Georgia-Pacific in asbestos litigation.
• The denial of the bankruptcy plan and the decision to litigate individual cases is a departure from the trend of seeking global settlements, as seen in cases like Purdue Pharma's opioid litigation.
• Johnson & Johnson's strong defense in ovarian cancer cases (16 wins out of 17) is a notable achievement compared to other companies facing mass tort claims.

Legal Proceedings

• The company faces ongoing litigation related to talc claims.
• The U.S. Bankruptcy Court for the Southern District of Texas denied Red River Talc LLC's request to confirm its proposed prepackaged bankruptcy plan.

Stakeholder Impact

• Shareholders may experience uncertainty due to the ongoing litigation.
• Employees may be affected by the company's strategic shift.
• Customers may have concerns about the safety of the company's products.
• Suppliers and creditors may be affected by the company's financial performance.

Next Steps

• Johnson & Johnson will return to the tort system to litigate and defeat talc claims.
• The company will adjudicate motions pending in the Multi-District Litigation to exclude plaintiffs experts and to disqualify the lead counsel.
• Johnson & Johnson will conduct a conference call with investors on April 1, 2025.

Key Dates

Keywords

talc, litigation, bankruptcy, Red River Talc, Johnson & Johnson, settlement, claims, tort system